Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd
is in the business of trading of Pacemakers.[1]
- Market Cap ₹ 50.8 Cr.
- Current Price ₹ 136
- High / Low ₹ 283 / 90.0
- Stock P/E 16.3
- Book Value ₹ 48.3
- Dividend Yield 0.00 %
- ROCE 22.6 %
- ROE 18.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Promoter holding has increased by 4.74% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 36.4%
- Company has high debtors of 179 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.49 | 7.40 | 6.84 | 6.60 | 7.27 | 8.76 | 7.56 | 9.03 | 20.19 | 22.04 | 16.68 | 21.64 | 21.19 | |
| 5.34 | 6.22 | 6.34 | 5.80 | 6.52 | 7.52 | 6.45 | 7.44 | 14.75 | 16.29 | 14.46 | 16.56 | 16.06 | |
| Operating Profit | 1.15 | 1.18 | 0.50 | 0.80 | 0.75 | 1.24 | 1.11 | 1.59 | 5.44 | 5.75 | 2.22 | 5.08 | 5.13 |
| OPM % | 17.72% | 15.95% | 7.31% | 12.12% | 10.32% | 14.16% | 14.68% | 17.61% | 26.94% | 26.09% | 13.31% | 23.48% | 24.21% |
| -0.15 | -0.08 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.09 | 0.14 | 0.12 | 0.12 | 0.12 | |
| Interest | 0.41 | 0.35 | 0.38 | 0.31 | 0.30 | 0.36 | 0.34 | 0.28 | 0.30 | 0.45 | 0.60 | 0.39 | 0.30 |
| Depreciation | 0.68 | 0.69 | 0.57 | 0.39 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.82 | 0.70 | 0.73 | 0.74 |
| Profit before tax | -0.09 | 0.06 | -0.40 | 0.11 | 0.24 | 0.41 | 0.31 | 0.88 | 4.60 | 4.62 | 1.04 | 4.08 | 4.21 |
| Tax % | -66.67% | 116.67% | -27.50% | 36.36% | 41.67% | 31.71% | 41.94% | 26.14% | 29.35% | 27.49% | 26.92% | 26.23% | |
| -0.04 | -0.01 | -0.29 | 0.08 | 0.14 | 0.28 | 0.18 | 0.65 | 3.25 | 3.36 | 0.75 | 3.02 | 3.11 | |
| EPS in Rs | -0.11 | -0.03 | -0.81 | 0.22 | 0.39 | 0.78 | 0.50 | 1.81 | 9.03 | 9.33 | 2.08 | 8.05 | 8.45 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 77% |
| 5 Years: | 76% |
| 3 Years: | -2% |
| TTM: | 193% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 48% |
| 3 Years: | -19% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.75 |
| Reserves | 1.81 | 1.80 | 1.51 | 1.70 | 1.84 | 2.11 | 2.30 | 2.95 | 6.20 | 9.56 | 10.31 | 14.36 |
| 2.69 | 1.89 | 2.64 | 2.30 | 2.94 | 2.64 | 2.73 | 2.88 | 2.16 | 4.27 | 4.97 | 2.61 | |
| 0.95 | 1.31 | 1.28 | 1.29 | 1.27 | 1.99 | 2.07 | 2.62 | 4.64 | 4.39 | 4.16 | 5.03 | |
| Total Liabilities | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 21.82 | 23.04 | 25.75 |
| 2.89 | 2.40 | 1.94 | 1.84 | 2.36 | 2.43 | 2.65 | 2.51 | 3.07 | 3.60 | 3.34 | 3.76 | |
| CWIP | 0.00 | 0.00 | 0.77 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 |
| Investments | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.65 |
| 5.36 | 5.40 | 5.52 | 6.25 | 6.49 | 7.00 | 7.25 | 8.74 | 12.73 | 17.42 | 18.90 | 20.68 | |
| Total Assets | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 21.82 | 23.04 | 25.75 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 1.32 | 0.57 | 0.08 | 0.63 | 1.49 | 0.99 | 0.59 | 2.40 | -0.03 | 0.05 | 3.87 | |
| -0.49 | -0.21 | -0.89 | 0.45 | -0.75 | -0.56 | -0.58 | -1.10 | -1.41 | -1.67 | -0.03 | -1.92 | |
| 0.19 | -1.11 | 0.24 | -0.48 | 0.26 | -0.81 | -0.15 | -0.14 | -0.96 | 1.75 | 0.12 | -1.42 | |
| Net Cash Flow | 0.07 | 0.00 | -0.07 | 0.06 | 0.14 | 0.12 | 0.26 | -0.65 | 0.03 | 0.05 | 0.14 | 0.53 |
| Free Cash Flow | -0.13 | 1.12 | -0.31 | 0.56 | -0.14 | 0.81 | 0.38 | 0.26 | 1.21 | -1.37 | -0.67 | 1.50 |
| CFO/OP | 38% | 112% | 138% | 10% | 87% | 125% | 105% | 46% | 61% | 19% | 52% | 94% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64.68 | 78.92 | 102.46 | 174.20 | 154.13 | 162.50 | 194.57 | 209.78 | 108.65 | 96.22 | 165.87 | 179.46 |
| Inventory Days | 746.59 | 359.32 | 373.73 | 301.93 | 270.24 | 217.26 | 272.02 | 194.20 | 157.41 | 285.83 | 463.17 | 275.46 |
| Days Payable | 33.18 | 32.67 | 27.63 | 48.31 | 33.93 | 53.23 | 47.19 | 17.55 | 32.22 | 12.45 | 57.32 | 69.58 |
| Cash Conversion Cycle | 778.09 | 405.57 | 448.55 | 427.83 | 390.45 | 326.53 | 419.40 | 386.43 | 233.84 | 369.59 | 571.72 | 385.35 |
| Working Capital Days | 96.17 | 104.07 | 90.72 | 139.36 | 104.93 | 83.33 | 98.01 | 108.73 | 86.05 | 120.23 | 180.31 | 179.13 |
| ROCE % | 3.83% | 5.33% | -0.40% | 5.47% | 5.13% | 9.09% | 7.54% | 12.51% | 45.82% | 34.50% | 9.03% | 22.58% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Cumulative pacemaker implants count |
|
|||||
| India revenue share (domestic vs export mix) % |
||||||
| Number of permanent employees count |
||||||
| R&D expenditure INR lakhs |
||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Kindly find enclosed herewith the extracts of Newspaper Publication Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015 of the Unaudited Standalone and Consolidated Financial …
-
Announcement under Regulation 30 (LODR)-Change in Directorate
- Board approved reappointment of JMD Akash Sethi and independent directors Manali Tongia, Somya Chhabra.
-
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June,2026
- No deviation in utilisation of Rs 243.48 lakh preferential issue funds for quarter ended 30 June 2026.
-
Corporate Announcement/Information Pursuant To Regulation 44 Of SEBI (LODR) Regulations, 2015 Regarding Providing E-Voting Facilities For The 38Th Annual General Meeting To Be Held On Tuesday, 29Th September, 2026.
- Company announces e-voting for 38th AGM on 29 September 2026; voting opens 26 September and closes 28 September.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board approved reappointment of Akash Sethi, Manali Tongia and Somya Chhabra, subject to AGM approval.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
SPL is in the business of delivering MRI safe life saving critical medical devices that regulate heart rhythms and improve the quality of life for patients suffering from cardiac conditions
such as arrhythmias and heart failure.